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Effect of Asbestos on the Metabolism of
Vasoactive Substances in Isolated
Perfused Guinea Pig Lungs
by Alain Cadieux,* Serge Masse* and Pierre Sirois*
The measurement of pulmonary metabolism of three vasoactive substances and quantitative assess-
ment of changes in lung morphology were performed in a long-term study of asbestos-exposed guinea
pigs. Animals received intratracheal injections of a single dose of a sterile suspension of Canadian
chrysotile B (5 mg), while control animals received only saline. Six months after the treatment, the
guinea pigs were sacrificed, the lungs removed, perfused via the pulmonary artery and the metabo-
lism ofvasoactive substances was assessed (in vitro) in a cascade superfusion system. At the end ofthe
experiments, the lungs were fixed in a glutaraldehyde solution for microscopic examination. The
tissue response consisted of both inflammatory reaction of terminal and respiratory bronchioles and
diffuse alveolar septal infiltration with interstitial fibrosis. The reaction was characterized at six
months by a progressive bronchiolitis obliterans with fibroblastic proliferation and collagen for-
mation. The development of the disease did not cause significant changes in the metabolism of
acetylcholine and bradykinin. However, the metabolism of prostaglandin E2 decreased with the ap-
pearance of the bronchiolitis obliterans. Our results showed that asbestos exposure may produce ear-
ly biochemical changes resulting in altered lung metabolism of vasoactive substances; these modifica-
tions could contribute to the pathogenesis of asbestosis.
Introduction
Lungs occupy a strategic position in the body.
This organ establishes the principal link between the
external environment and the organism. Besides its
ability to perform vital gas exchanges, the respira-
tory system is also designed to protect the body
against external intruders such as infectious agents
or foreign materials. These important defense func-
tions depend on the combined and integrated effects
of several mechanisms, namely the action of the pul-
monary macrophages, the mucociliary transport and
the immune system (1).
On the other side of this biological barrier, the
lungs are also involved in the hormonal control of
blood circulation. The vast surface covered by the
pulmonary vascular bed and especially the numerous
enzymatic activities found on and in the capillary en-
dothelial cells give to the respiratory system the ca-
pabilities ofactivating and inactivating a large series
of vasoactive substances (2, 3). Disturbance of these
basic physiological processes with physical or chemi-
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cal means could have dramatic consequences on ho-
meostasis.
The aim of the following experiments was to in-
vestigate the effects of asbestos exposure on the
nonrespiratory functions of the lungs. The fate of
bradykinin, acetylcholine and prostaglandin E2 in the
pulmonary circulation ofguinea pigs following asbes-
tos exposure was studied.
Materials and Methods
Experimental Asbestosis
Guinea pigs of either sex weighing between 350
and 450 g were given a single intratracheal injection
of 0.25 mL of a 20 mg/mL sterile suspension ofCana-
dian chrysotile B (UICC). The total amount of asbes-
tos fibers introduced intothe lungs was 5 mg per ani-
mal. They were housed four to six per cage and kept
under constant environmental conditions until use.
Water and food were givenad libitum.
Isolated Lung Preparation and Bioassay
Six months after the administration of the asbes-
tos suspension, the animals were sacrificed by cervi-CA2DIEUX, MASSEAND SIROIS
cal dislocation. The thorax was opened and heparin
(500 IU) was given intracardially. The lungs were re-
moved and perfused via the pulmonary artery with
oxygenated Krebs solution at 370C essentially as de-
scribed previously by Alabaster and Bakhle (4). The
perfusion rate was maintained at 5 mL/min, and the
effluent from the lungs superfused over selected iso-
lated smooth muscles preparations in a cascade per-
fusion system (5). The following assay tissues were
used: the rat stomach strip (6) for prostaglandin E2
(PGE2), the guinea pig ileum (7) for bradykinin (BK)
and the external muscular layer of the guinea pig I-
eum (8) for acetylcholine (Ach). The specificity and
stability ofthe tissular response were insured bythe
infusion ofa mixture ofinhibitors containing: methy-
sergide (M), 0.5,g/mL; propranolol (P), 3.0 ,ug/mL;
phentolamine (Ph), 1.0pg/mL; atropine (A), 0.5,g/ml;
and diphenhydramine (D), 1.0 Ag/mL for the bioassay
ofPGE2 and BK and by the infusion ofM.P.Ph.D. for
the bioassay of Ach. The perfusion solution also con-
tained indomethacin (1.0,ug/mL) to preventrelease of
prostaglandins from the lung. Contractions ofthe as-
say tissues were recorded with isometric force dis-
placement transducers (Grass FT03) attached to a
multichannel Grass polygraph (Model 7D). The
amount ofBK, Ach and PGE2 removed from the per-
fusion medium by the lungs was determined by com-
paring the contraction of the assay tissues to bolus
injections given directly into the superfusing fluid
with responses to bolus injection given through the
pulmonary arterial cannula.
Histopathological Methods
At the end of each perfusion, the lungs were fixed
by immersion in a phosphate-buffered 4% formalde-
hyde-1% glutaraldehyde solution for histological ex-
amination (9). Representative 5,um paraffin sections
were cutand stained with hematoxylin-eosin.
Drugs
Acetylcholine chloride and atropine sulfate were
purchased from Sigma Chemical Co. The following
drugs were supplied as generous gifts: prostaglandin
E2 (Dr. J. E. Pike of UpJohn Co.), bradykinin (Dr. D.
Regoli, Dept. Pharmac., University of Sherbrooke),
methysergide hydrogen maleate (Sandoz Ltd), pro-
pranolol hydrochloride (Dr. L. Smith, Ayerst), phen-
tolamine hydrochloride (Ciba Lab.), diphenhydra-
mine hydrochloride (Dr. E. McMullen of Parke,
Davis & Co.) and indomethacin (Merck Frosst Lab.).
PGE2, BK and Ach were dissolved in Krebs solu-
tion just before use. Suspension of Canadian
chrysotile B (UICC) (20 mg/mL) were made in
physiological saline and autoclaved before use.
Results
Morphological Effects of Asbestos on
Guinea Pig Lungs
The histological appearance of the lungs of guinea
pigs exposed to chrysotile asbestos is shown in Fig-
ures 1 and 2. In general, the morphological changes
are representative ofthe early stage ofdevelopment
ofthe disease. Intratracheal injections produced non-
uniform distribution of the asbestos fibers, and con-
sequently the repartition of pulmonary lesions is
slightly different from one animal to the other. After
6 months of exposure, some large fibers persisted in
small airways but most of the smallest ones were
found in the adjacent interstitial spaces and alveoli.
Distal lung structures were more affected, and the
most significant lesions were located in and around
terminal bronchioles. They were characterized by
three principal manifestations. The first and main
feature observed was a granulomatous mainly peri-
bronchiolar reaction which resulted in severe struc-
tural distortion of the terminal and respiratory
bronchioles. As seen in Figure 1, the zone of reac-
tion was sometimes so extensive as to also
obliterate surrounding alveolar spaces. Asbestos
bodies were present in great numbers in these
areas but were not apparent with the type of stain-
ing used on Figure 1. A few sites of cuboidal
metaplasia of some alveolar walls, always adjacent
to damaged bronchioles, led to the apparition of an
adenomatoid appearance. Finally, focal fibroblastic
proliferation induced in peribronchiolar tissues
distorted ai. i obstructed small airways (Fig. 2).
These features of peribronchiolitis and bronchioli-
tis obliterans were seen in all animals exposed to
chrysotile asbestos.
Metabolic EffectsofAsbestos
The effect ofexposure to asbestos dust on the pul-
monary metabolism of bradykinin, acetylcholine and
prostaglandin E2 is shown in Figure 3. These record-
ings represent the results of typical experiments in
which the three assay tissues were directly super-
fused with the effluent from perfused guinea pig
lungs. Each one has been selected from different ex-
periments. For each substance studied, bolus injec-
tions through the pulmonary artery were repeated
with three different doses (in triplicate). Values of
percent removal obtained with each of the sub-
stances represent the meanofnineconsecutiveinjec-
tions.
As shown on Table 1, no changes in the inactiva-
tion of bradykinin were observed in treated lungs
when compared to control animals. The lungs re-
moved 88% of a bolus injection of 100 to 400 ng of
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FIGURE 1. Guinea pig asbestosis. The photomicrograph reveals the peribronchiolar granulomatous reaction. Note the severe
structural distortion of the respiratory bronchiole. Arrow points out an area of so called "adenomatoid" appearance formation.
Table 1. Removal of bradykinin (BK), acetylcholine (Ach)
and prostaglandin E2 (PGE2) in isolated normal
and asbestotic guinea pig lungs.
Drugs (and Removal,o%a
doses used, ng) Control Asbestos (6 months)
BK (100-400) 87.9 ± 1.86(30) 87.6 ± 1.96(21)
Ach (100-1000) 82.4 ± 2.7 (11) 82.0 ± 2.8 (5)
PGE2 (1-20) 83.0 ± 3.02(18) 63.6 ± 5.2 (20)
aResults are expressed as mean ± SEM. The number of ex-
periments is given in parentheses. For details, see "Materials
and Methods" and Figure 3.
the peptide given through the pulmonary circulation.
This high degree of inactivation was maintained at
the same level after 6 months ofchrysotile exposure.
The same phenomenon was observed with the
cholinergic agonist. Mean values of 82% of lung re-
moval (as measured by the changes of the height of
thepeaks)remained unchanged for doses from 100 to
1000 ngofAch in controls and in treated animals. An
average of 18% ofthe amount injected was detected
in thelungperfusates (16experiments).
In contrast to these results, the removal ofprosta-
glandin E2 was significantly altered (p<0.005) by as-
bestos exposure. From 83% in the control animals,
the inactivation ofPGE2 decreased to 63% when the
fatty acids were passed through lungs of exposed
guinea pigs. This diminution in the metabolism was
reproduced with doses of 1 to20 ngofPGE2. In other
words, the effect of asbestos treatment causes two-
fold increases in the amount of PGE2 emerging from
the lungs following a single bolus injection.
Discussion
Asbestosis is a chronic disease which requires
several years to develop in humans. In experimen-
tal animals, it is not only possible to reproduce the
characteristic tissue damages of asbestos exposure
but mainly to accelerate their apparition by injec-
ting the fibers directly into the trachea (10). Our
results showed that intratracheal injections of
asbestos to guinea pigs induced in a few months a
fibroblastic proliferation with all the main features
of the bronchiolitis obliterans. Although the distri-
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FIGURE 2. Guinea pig asbestosis. Late stage of bronch
chiole is almost obliterated by the cellular invasion.
CONTROL
oroblastic proliferation. The lumen of the bron-
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FIGURE 3. Typical recordings of the pulmonary inactivation of bradykinin (BK), acetylcholine (Ach) and prostaglandin E2 (PGE2) in
control guinea pigs (left) and in animals which have received intratracheal injection of 5 mg of asbestos fibers 6 months before
(right). The top record shows contractions of the guinea pig ileum (GPI) to BK. The middle one represents the contractions of
the external muscular layer of guinea pig ileum (GPI/EML) to Ach, and the bottom one shows the response of the rat stomach
strip (RSS) to PGE2. For each substances, the doses have been injected either directly (DIR) over the superfused tissue or
through the lung (IA) via the pulmonary artery.
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bution and the degree of development of the disease
was slightly variable from one animal to the other,
the three histological manifestations, namely, the
peribronchiolar reaction, the adenomatoid appear-
ance of the tissue adjacent to the damaged bronchi-
oles and the focal fibroblastic proliferation, were
present in most animals. These morphological
changes, consistent with the development of pulmo-
nary fibrosis, confirmed the findings reported by
several investigators with rats (11), hamsters (12)
and guinea pigs (13,14).
During the development of experimental asbes-
tosis in guinea pigs, the pulmonary metabolism of
bradykinin and acetylcholine was not altered. The
values remained, respectively, at 88% and 82% of
metabolism for controls and for asbestos-treated ani-
mals. However, the metabolism of prostaglandin E2
was significantly reduced by asbestos treatment. It
fell from 83% in control animals to 63% in treated
ones. Although a 20% decrease in pulmonary re-
moval may appear of minor importance, it means
that twice as much prostaglandin can escape lung
metabolism (from 17% of the dose injected in con-
trols to 37% in treated animals) and enter the sys-
temic arterial circulation.
These findings are particularly interesting since
they pointed out a marked difference among the
mechanisms involved in the pulmonary metabolism
ofthe three substances studied.PGE2 istheonly sub-
stance of the three which need to enter the cells to
be metabolized. Bradykinin is destroyed by a con-
verting enzyme located on the luminal surface ofthe
pulmonary endothelial cells (15), whereas acetylcho-
line is believed to be inactivated by local cholinester-
ase (16). Prostaglandin inactivation in lungs depends
on an active uptake intothe cells and subsequent me-
tabolism by intracellular enzymes. The activity of
the 15-hydroxyprostaglandin dehydrogenase was
found to be the rate-limiting step ofPGs inactivation
(17). Our findings suggest that the decrease observed
in the pulmonary metabolism of PGE2 could be due
either to the inhibition of this enzyme or to inhibi-
tion of its transport into the cells. But how such an
injury to the lung could interfere with the activity
of this intracellular enzyme or with the membrane
transport remains an open question. Further
studies are needed to clarify the phenomenon.
In summary, our results have shown that intratra-
cheal injections ofasbestos fibers in guinea pigs pro-
duced a bronchiolitis obliterans with fibroblastic pro-
liferation and collagen formation and altered the pul-
monary inactivation of prostaglandin E2 but not of
bradykinin and acetylcholine. The physiological sig-
nificance of these findings as well as the role of lung
metabolism in homeostasis remains speculative.
This study was supported by Quebec Lung Association and
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